Related Experiment Video
Updated: Sep 5, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Skeletal Effects of Inducible ERα Deletion in Osteocytes in Adult Mice
Madison L Doolittle1, Dominik Saul1, Japneet Kaur1
1Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Abstract:
Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ERα) regulation of adult bone metabolism. Studies using global ERα-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ERα deletion may be confounded by ERα effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1CreERT2 ). These mice were crossed with ERαfl//fl mice to create ERαΔOcy mice, permitting inducible osteocyte-specific ERα deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ERαΔOcy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ERαΔOcy mice compared to control (Dmp1CreERT2 ) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ERαΔOcy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ERαΔOcy mice. These findings thus establish that osteocytic ERα is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ERαΔOcy mice provides a direct link in vivo between ERα and Wnt signaling. © 2022 American Society for Bone and Mineral Research (ASBMR).
Insights
Osteocyte-specific estrogen receptor alpha (ERα) deletion in adult female mice significantly reduced bone formation and altered bone structure. This highlights ERα
Area of Science:
- Endocrinology
- Bone Biology
- Genetics
Background:
- Estrogen plays a crucial role in regulating bone metabolism in both sexes.
- Gaps exist in understanding estrogen receptor alpha (ERα) regulation of adult bone.
- Previous studies using global ERα-knockout mice had confounding factors.
Purpose of the Study:
- To investigate the specific role of ERα in osteocytes in adult bone metabolism.
- To develop a mouse model for inducible, osteocyte-specific ERα deletion.
Main Methods:
- Developed Dmp1CreERT2 mice crossed with ERαfl//fl mice to create ERαΔOcy mice.
- Administered tamoxifen to induce osteocyte-specific ERα deletion in adult mice.
- Analyzed bone structure, formation rates, and gene expression in female and male mice.
Main Results:
- Female ERαΔOcy mice showed reduced spine bone volume, decreased trabecular bone formation, and lower serum P1NP.
- Periosteal and endocortical expansion increased in ERαΔOcy mice, consistent with estrogen's known effects.
- Increased Sost mRNA levels and downregulation of osteoblast/Wnt target genes were observed in ERαΔOcy mice.
Conclusions:
- Osteocytic ERα is critical for estrogen's action in adult female bone metabolism, but not in males.
- This study establishes a direct in vivo link between ERα and Wnt signaling in bone.
- Findings provide new insights into sex-specific mechanisms of estrogen in bone health.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling

